CEACAM5 and familial pancreatic carcinoma: Furthermore, miR-17-5p methylation level in serum samples distinguished early pancreatic cancer patients from healthy controls with higher sensitivity and specificity than established biomarkers such as carbohydrate antigen 19–9 (CA19–9) and carcinoembryonic antigen (CEA) [109].